Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting methylphenidate for academic activity in children with ADHD
2012-000492-17Phase 4Active
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: Academic effort and engagement improvement, Academic abilities improvement and 3 more. Started Mar 2012; status: active.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2012-000492-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000492-17.